Study to improve hereditary cancer genetic testing access
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study helps people with cancer learn about genetic testing for hereditary cancer. It aims to improve access to testing and support for those who may have an inherited risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of cancer that may be linked to hereditary (inherited) forms.
- You have not previously had a multi-gene panel test for hereditary cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a video-based education approach that shares information differently depending on someone’s genetic test results. It may help people better understand cancer-related genetic information and what it could mean for them.
This study tests new educational materials about genetic testing for cancer patients. It aims to find the best ways to explain genetic testing to people from different backgrounds, especially Black, Latino, and non-Latino non-Black communities.
This study helps prostate cancer survivors get genetic testing for inherited cancer risk. It aims to make testing easier to access and understand.
This study offers free genetic testing to Black or African American people who have had certain cancers. It aims to find inherited gene changes that increase cancer risk and improve health equity.
This study looks at genetic changes linked to breast, ovarian, or digestive cancers. It may help doctors better understand inherited cancer risks.
This trial aims to increase the use of genetic testing (germline testing) among cancer patients by working with healthcare providers like oncologists and nurses. If you are an oncology care team member treating adults with breast, pancreatic, or colorectal cancer, this study may be for you.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.